AIG
TERN

American International Group’s Terns Pharmaceuticals TERN Stock Holding History

American International Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,370
Closed -$140K – 2444
2024
Q1 		$140K Buy
21,370
+69
+0.3% +$451 ﹤0.01% 2338
2023
Q4 		$138K Sell
21,301
-86
-0.4% -$455 ﹤0.01% 2371
2023
Q3 		$108K Buy
21,387
+760
+4% +$4.82K ﹤0.01% 2472
2023
Q2 		$180K Buy
+20,627
New +$240K ﹤0.01% 2230
2022
Q2 		– Sell
-6,811
Closed -$20K – 3259
2022
Q1 		$20K Sell
6,811
-478
-7% -$2.04K ﹤0.01% 3030
2021
Q4 		$52K Sell
7,289
-218
-3% -$1.81K ﹤0.01% 2946
2021
Q3 		$78K Buy
7,507
+2,624
+54% +$27.2K ﹤0.01% 2886
2021
Q2 		$60 Sell
4,883
-192
-4% -$3.27K ﹤0.01% 2977
2021
Q1 		$112 Buy
+5,075
New +$111K ﹤0.01% 2658

Other funds holding TERN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

American International Group's TERN Position: Q2 2024 in Review

American International Group sold out of Terns Pharmaceuticals (TERN) in Q2 2024, closing a stake of 21,370 shares — an estimated $140K sold.

American International Group first reported a position in TERN in Q1 2021 and held it in 9 quarters. The position peaked at $180K in Q2 2023. 126 funds tracked by Wall St. Rank hold TERN as of Q2 2024.

  • American International Group reported no remaining Terns Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 21,370 Terns Pharmaceuticals shares in Q2 2024, an estimated $140K.
  • American International Group first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 9 quarters.
  • American International Group's Terns Pharmaceuticals position peaked at $180K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.